 Home > Medical News > Latest Medical News > BeiGene initiates a phase 1 clinical trial of HPK1 inhibitor

BeiGene initiates a phase 1 clinical trial of HPK1 inhibitor

 Last Update: 2021-03-21
 Source: Internet
 Author: User

Tags

clinical trial regulation

plasma cells blood

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Source: Guanlan Pharmaceutical

Recently, BeiGene announced that a phase 1 clinical trial of its in-development hematopoietic stem cell kinase 1 (HPK1) inhibitor BGB-15025 has completed its first patient administration.

HPK1 is a key negative feedback regulator of T cell receptor (TCR) signaling and is believed to play a key role in the anti-tumor immune response.

The press release shows that the first phase 1 clinical trial in humans launched this time aims to evaluate the safety, tolerability, and pharmacokinetics of BGB-15025 as a single agent or in combination with Bezan in patients with advanced solid tumors.

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

BeiGene initiates a phase 1 clinical trial of HPK1 inhibitor...

03-25

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

BeiGene initiates a phase 1 clinical trial of HPK1 inhibitor

Related Articles

BeiGene initiates a phase 1 clinical trial of HPK1 inhibitor...